Personalized Medication Software for BCL-2 Inhibitor in AML Patients Using Machine Learning and Genomics

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Personalized Medication Software for BCL-2 Inhibitor in AML Patients Using Machine Learning and Genomics	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm	Not yet recruiting	Not stated	2024-03-06		NCT06295029

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School	164

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials